-
- QuintilesIMS Kundentagung 2016: Aktuelle Trends und Entwicklungen in der Gesundheitsbranche
- Führende pharmazeutische Unternehmen in Deutschland im Jahr 2015
- IMS Brogan Recognizes Quebec Health Professionals for their Contribution to the Appropriate Use of Medicines
- IMS Health Acquires TTC, Strengthening Pharma R&D Services Capabilities
- IMS Health Reports First-Quarter 2015 Results
-
-
Big C - beyond drugs and treatments to support
BusinessLine
As much as advice on drugs and therapy, patients need help with funds, tackling drug shortages and even a place to stay.
-
Innovators 2016: Strategies
PM360
Orchestrated Customer Engagement (OCE) was recently chosen by PM360 as one of the most innovative strategies of 2016. The Innovations issue commended QuintilesIMS for OCE’s evolutionary approach to customer-facing teams’ interactions, communications, and collaborations with each other and HCPs (healthcare providers), so that the overall experience is more effective.
-
The CRM journey: linking CRM to revenue in pharma
Pharmaceutical Market Europe (PME)
This is not just another article encouraging pharma to make better use of CRM. Instead, commercial excellence leaders from QuintilesIMS provide evidence of a direct correlation between optimized CRM and improved business performance.
-
Artificial Intelligence is Pharma’s Next Frontier in Customer Relationships
PM360
While a top performing sales person may have the ability to instinctively read customers, it’s likely the rest of the team could use a little help in drilling down to what a customer wants. That help has arrived in the form of Artificial Intelligence (AI). Emiliano Gummati of QuintilesIMS explains how life sciences companies can train AI algorithms to drive business decisions to achieve greater success
-
What’s on the Horizon for the Life Sciences CIO? A Horizontal View
CIO Review
Richie Etwaru, Chief Digital Officer of QuintilesIMS, explains the critical role the C-level technology officer will play in pharm’s quest to provide orchestrated customer engagement. Delivering a coordinated and satisfying customer experience requires pharma companies to evolve away from vertical silos, to a horizontal operating model with a foundation of shared data.
-
Big C - beyond drugs and treatments to support